Literature DB >> 84866

Transsphenoidal hypophysectomy for disseminated carcinoma of the prostate gland. Results in 53 patients.

G T Tindall, N S Payne, D W Nixon.   

Abstract

Transsphenoidal microsurgical hypophysectomy was performed in 53 men with disseminated carcinoma (Stage IV) of the prostate gland. The mean age was 64.8 years. Forty-three of the 53 men had severe pain due to their disease. Significant pain relief was obtained following hypophysectomy, usually within 24 hours, in 39 (91%) of these 43 patients. Objective remission occurred in 16 (36%) of 45 patients in whom the follow-up review was adequate to make this decision. Although dramatic, pain relief was not permanent in every patient. Four patients died in the early postoperative period, and in one, death was directly related to the operative procedure. Significant complications included partial diabetes insipidus in 40 cases (75.5%), and cerebrospinal fluid leaks in six (11.3%). The authors conclude that hypophysectomy is an appropriate operation in patients with disseminated carcinoma of the prostate gland, particularly when pain is a significant feature of the illness. Further, the transsphenoidal microsurgical approach appears to be the operative procedure of choice for performing hypophysectomy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 84866     DOI: 10.3171/jns.1979.50.3.0275

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  Neurosurgical treatment of chronic pain.

Authors:  F Takeda
Journal:  Postgrad Med J       Date:  1984-12       Impact factor: 2.401

2.  Automated Stereotactic Gamma Ray Radiosurgery to the Pituitary Gland in Terminally Ill Cancer Patients with Opioid Refractory Pain.

Authors:  Eduardo E Lovo; Fidel J Campos; Victor E Caceros; Mario Minervini; Claudia B Cruz; Juan C Arias; William A Reyes
Journal:  Cureus       Date:  2019-06-03

3.  Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

Authors:  B A Ponder; R J Shearer; R D Pocock; J Miller; D Easton; C E Chilvers; M Dowsett; S L Jeffcoate
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.